In Pursuit of Precision: Certis Oncology Intelligence
Certis is an AI-enabled precision oncology and translational science company.  Our product is Oncology Intelligence®—highly predictive therapeutic response data derived from advanced models of cancer.  We partner with oncology therapeutics developers to help close the problematic translation gap between preclinical studies and clinical trials. Using CertisAI™, our proprietary artificial intelligence/machine learning platform, and more clinically relevant, patient-derived tumor models, we bring certainty to lead candidate selection and help secure clear and compelling evidence of drug efficacy.

We offer a rapidly growing collection of highly characterized tumor models representing the full spectrum of solid cancers and comprehensive in vitro and in vivo services—including a suite of advanced imaging, comprehensive in-house immunohistochemistry, and an array of high-precision immuno-oncology, biochemical and cellular bioassays.

Established in 2016, Certis operates a CLIA-certified laboratory in Sorrento Valley, the heart of San Diego’s life sciences industry. To learn more, visit www.certisoncology.com.